Control group | Saline group | Saline/TA group | ||||
Median | IQR | Median | IQR | Median | IQR | |
UWS (mL/min) | ||||||
T0 | 0.09 | 0.03–0.18 | 0.10 (*, †) | 0.04–0.19 | 0.10 (‡) | 0.06–0.17 |
T1 | 0.08 | 0.04–0.21 | 0.10 | 0.03–0.50 | 0.11 (§) | 0.05–0.22 |
T8 | 0.07 | 0.04–0.27 | 0.14 (*) | 0.07–0.48 | 0.09 (¶) | 0.06–0.22 |
T16 | 0.10 | 0.02–0.28 | 0.13 (†) | 0.04–0.45 | 0.11 | 0.05–0.27 |
T24 | 0.12 | 0.03–0.22 | 0.16 | 0.07–0.38 | 0.12 (‡, §, ¶) | 0.08–0.27 |
SWS (mL/min) | ||||||
T0 | 0.25 | 0.15–0.73 | 0.25 (*) | 0.07–0.70 | 0.37 (‡) | 0.13–0.62 |
T1 | 0.18 | 0.11–0.74 | 0.35 | 0.08–0.72 | 0.36 (§, ¶, †) | 0.20–0.60 |
T8 | 0.22 | 0.16–0.71 | 0.33 | 0.08–0.67 | 0.45 (§, **, ††) | 0.18–0.77 |
T16 | 0.24 | 0.10–0.56 | 0.33 | 0.09–0.68 | 0.64 (‡, ¶, **) | 0.17–0.90 |
T24 | 0.25 | 0.11–0.67 | 0.30 (*) | 0.09–0.81 | 0.61 (†, ††) | 0.19–0.80 |
SPF (mL/min) | ||||||
T0 | 0.17 | 0.00–0.47 | 0.11 | 0.00–0.22 | 0.18 (*) | 0.03–0.47 |
T1 | 0.05 | 0.00–0.65 | 0.03 | 0.00–0.21 | 0.11 (†) | 0.03–0.35 |
T8 | 0.13 | 0.00–0.41 | 0.08 | 0.01–0.30 | 0.16 | 0.06–0.41 |
T16 | 0.06 | 0.00–0.66 | 0.09 | 0.00–0.33 | 0.22 | 0.05–0.42 |
T24 | 0.06 (¶) | 0.00–0.26 | 0.02 (§) | 0.00–0.50 | 0.34 (*, †, ¶, §) | 0.19–0.73 |
CODS (1–10) | ||||||
T0 | 3 | 2–4 | 3 (*) | 2–4 | 2 (‡, ††, §§, §) | 2–3 |
T1 | 3 (¶) | 2–3 | 1.5 (*, ¶) | 0–3 | 1.5 (‡) | 1–2 |
T8 | 2 | 2–4 | 1.5 | 1–3.75 | 2 (††, ‡‡) | 0.75–3 |
T16 | 2 | 1–4 | 2 | 1–3 | 1 (§§) | 0–2 |
T24 | 2 | 2–3 | 1.5 | 1–3 | 1 (§, ‡‡) | 0–2 |
XI (11–55) | ||||||
T0 | 48 | 41–51 | 45 (*, †) | 41.25–48.75 | 45.5 (‡, §) | 38.5–50 |
T1 | 48 | 41–51 | 42 | 34.50–46 | 44.5 | 39–50.25 |
T8 | 47 | 40–50 | 41 | 34–46 | 44 (‡) | 37.50–47.25 |
T16 | 46 | 42–52 | 42 (*) | 32.25–45.75 | 42.5 (§) | 31.50–48.50 |
T24 | 47 | 42–51 | 38 (†) | 33–44 | 43.5 | 36.25–49.25 |
Data sharing the same symbols (*, †, ‡, §, ¶, **, ††, ‡‡, §§) differ significantly.
CODS, Clinical Oral Dryness Score; SPF, stimulated parotid flow; SWS, stimulated whole saliva flow; TA, triamcinolone acetonide; T0, 1 week before intervention; T1, 1 week after intervention; T8, 8 weeks after intervention; T16, 16 weeks after intervention; T24, 24 weeks after intervention; UWS, unstimulated whole saliva flow; XI, Xerostomia Inventory.